Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
about
Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.Role of nitric oxide synthase inhibitor in experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats.Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.Targeted deletion of neuropeptide Y (NPY) modulates experimental colitisReview article: the potential role of nitric oxide in chronic inflammatory bowel disorders.Peroxynitrite and inflammatory bowel diseaseInducible nitric oxide synthase: a little bit of good in all of usCurcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases.Small therapeutic molecules for the treatment of inflammatory bowel diseaseActivated eosinophils in association with enteric nerves in inflammatory bowel disease.Decreased development of necrotizing enterocolitis in IL-18-deficient miceCurcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitisThe intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression.Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.Nitric oxide synthesis in patients with infective gastroenteritisRole of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice.Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn.Novel approaches to inflammatory bowel disease.p53 mediates TNF-induced epithelial cell apoptosis in IBD.Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide.Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences.Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental study.Trp53 deficiency protects against acute intestinal inflammation.An insight into the possible protective effect of pyrrolidine dithiocarbamate against lipopolysaccharide-induced oxidative stress and acute hepatic injury in ratsNitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient miceColorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitisCellular and Molecular Mediators of Intestinal Fibrosis.Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.Cytosolic phospholipase A2 α has a crucial role in the pathogenesis of DSS-induced colitis in mice.Nitric oxide as a mediator of inflammation?-You had better believe it.Sulphydryl blocker induced gastric damage is ameliorated by scavenging of free radicals.Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro.Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.Cellular and molecular mechanisms of intestinal fibrosis.Hyperbaric oxygen: a novel modality to ameliorate experimental colitis.Intestinal anti-inflammatory effects of goat whey on DNBS-induced colitis in mice.Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice.Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis.
P2860
Q30322266-5E253AE9-0AB6-427A-B64E-793AA3B3A5FEQ31818190-DD8CC91C-67E6-4C73-8F2D-4155987FAD2CQ33340603-5260EE8F-B0B4-4540-973A-348ABE46EFC6Q33374011-D69267E3-A838-49E2-A7B1-07F777F578FCQ33548209-765DB165-B4B6-4B8C-AC4C-DDFC4EA8561EQ33836818-B0E04F52-3175-42F8-86DF-D3C36D9C3978Q33947042-B5EC4F4F-6015-4412-BB4E-F12CF5616D16Q34480991-C544F179-9D88-4ABF-A1D8-D8F34E8705C9Q34600992-147E1821-26AA-48F2-B695-D44072DABD34Q34745442-A8BC3972-42D0-4ECB-A06C-B7CC00338271Q34915365-2E898D3F-5105-4B0B-ACEC-4638CBB21C9FQ35045291-3CF108E8-CE5D-480D-A669-0C9E9D287C55Q35048387-D5C00B33-3426-4AA0-B6EC-DE73E00CAC5DQ35059717-D1BBEFCC-E412-4C8E-9EA5-DA57ACC27488Q35356639-B3815E5A-37D7-4646-BCCF-9B68FFDBC10EQ35357954-CA2C68CF-4D2E-4F9A-A621-B5A7F6060D3FQ35597438-51EA2D47-822E-46BF-AB5E-C65F0FF40F58Q36181229-A5629CDB-0AE0-4A02-B8AA-96F05131E4F5Q36295461-C5F982BF-E101-48FE-9D54-B032EAEB0DC5Q36376397-85B9E9DA-3AE4-4367-BCFD-55FC5F93EAF2Q36674023-CF3DEF00-E75B-415F-AB0B-B50BA1F7ED9DQ36840314-B2FC318A-1BA2-4712-8FDD-791073925E4AQ37008316-067A31BA-C229-491A-AE5D-A201345B15E5Q37063280-C5D729A2-E9B6-447D-B34E-18FA5AB7E48BQ37079014-CD4D45B3-D169-4DD6-822A-B5A62D96471DQ37365002-EDFD9674-3093-4BD7-A5A2-F71914514C0DQ38259227-6BDDA41C-D1EB-4EE6-8612-772E8FD045DCQ38610164-BFD88004-4725-4407-AAC5-3EB129B2863BQ39794841-4C69C14E-D1C8-490F-A02C-76AFB594CFEEQ40264330-C06BB35C-FE94-4149-AB00-08759505FE65Q40918255-2AFA447A-5632-4F66-9DCF-07B8843ABCCCQ42031614-0B98FEE4-822D-4AB7-B4D4-2FAFEA420834Q42069276-E9E5D1A0-6836-4AAB-AF20-F1C466ED6333Q42099871-F0A5070E-70D0-48AC-A3BC-6AFB3C570116Q42174364-DC75272B-82FD-420D-A4E0-BF8CDF002D04Q42252132-1113095E-DF89-44B2-B2B4-BD4FEEC67257Q42275037-73357252-0FC7-45E8-87E7-54D15BD09580Q42366229-A43EFF58-CA22-4A8B-9F8C-392B9D59F14AQ42844890-AB8E7138-1140-474C-93EB-8EBB609CB259Q43551315-A2F7A5D8-A0C1-40E4-9625-4C2D93EE391F
P2860
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@ast
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@en
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@nl
type
label
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@ast
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@en
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@nl
prefLabel
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@ast
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@en
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@nl
P2093
P2860
P356
P1433
P1476
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
@en
P2093
Bursztyn M
Rachmilewitz D
P2860
P304
P356
10.1136/GUT.37.2.247
P407
P577
1995-08-01T00:00:00Z